Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.

Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.

Show full CV Hide full CV

Latest news & insights

pipette
Synapse

COVID-19 and life sciences M&A

16 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Advising Glenmark on product portfolio sale

7 April 2020

by multiple authors

Click here to find out more
Patents & innovation

Taylor Wessing announces three new senior promotions

4 November 2019

by multiple authors

Click here to find out more
International arbitration

Arbitration considerations for life science companies

29 September 2019

by multiple authors

Click here to find out more

Related people

Meet me at

There are no upcoming events